Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
immediate hypersensitivity | allergic-type reaction developing rapidly after exposure | Immediate hypersensitivity was considered based on the documented sequence of hives and respiratory symptoms. | Assessment | Medication response, exposure and reconciliation |
interaction | one exposure alters another's effects | A drug interaction may account for the change in anticoagulant effect. | Assessment | Medication response and safety |
interpatient variability | differences in exposure or response among individuals | The team considers interpatient variability when reviewing the population-based estimate. | Assessment | Medication exposure, response and adverse-effect reasoning |
light-protective covering | cover used to limit light exposure of a specific preparation | Light-protective covering was in place on the labeled container. | Objective | Vascular access and infusion observations |
limited sampling strategy | specified subset of timed measurements used to estimate an exposure metric | The report names the validated limited sampling strategy used for the AUC estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
linear kinetics | concentration or exposure changes proportionally with dose under stated conditions | The dosing model assumes linear kinetics over the range examined. | Assessment | Drug levels - exposure and pharmacokinetics |
loading dose | initial dose intended to reach a target exposure more quickly | Record the actual loading dose amount and completion time. | Plan | Drug levels - verification and documentation |
| softened skin after moisture exposure | Maceration present between the fourth and fifth toes. | Objective | Skin, wounds and soft tissue | |
maintenance dose | ongoing dose intended to sustain exposure | Verify the maintenance dose before scheduling the next sample. | Plan | Drug levels - verification and documentation |
mycophenolic acid | active compound measured in certain mycophenolate exposure assessments | The mycophenolic acid report distinguishes the parent analyte from its glucuronide metabolite. | Objective | Drug levels - named analytes and exposure reports |
new steady state | stable repeating exposure after a regimen or clearance change | Review the interval since dose reduction before assuming a new steady state. | Plan | Drug levels - verification and documentation |
non-steady-state | sample obtained while exposure is still changing between dosing intervals | The team interpreted this as a non-steady-state sample after the dose increase. | Assessment | Drug levels - exposure and pharmacokinetics |
nonlinear kinetics | exposure changes out of proportion to the change in dose | The clinical pharmacist considered nonlinear kinetics when reviewing the concentration trend. | Assessment | Drug levels - exposure and pharmacokinetics |
odor-triggered headache | headache reported after exposure to particular smells | The patient describes odor-triggered headache after entering an area with a strong fragrance. | Subjective | Pain history and sensory descriptions |
opioid-induced hyperalgesia | increased pain sensitivity potentially associated with opioid exposure | Opioid-induced hyperalgesia was included in the differential for diffuse worsening pain. | Assessment | Medication response, exposure and reconciliation |
pharmacodynamic tolerance | less response at the same drug exposure after repeated use | Pharmacodynamic tolerance was considered after reviewing exposure and the clinical response. | Assessment | Medication response, exposure and reconciliation |
pharmacokinetic monitoring | review of dose, timing and measured exposure | The consult requests pharmacokinetic monitoring using actual administration times. | Plan | Drug levels - verification and documentation |
pre-steady-state trough | predose sample obtained before a stable repeating exposure profile is established | Pre-steady-state trough was interpreted with the recent regimen change documented. | Assessment | Medication response, exposure and reconciliation |
| re-exposure after a previous suspected reaction | The outside note describes symptom recurrence after an inadvertent rechallenge. | Assessment | Medication exposure, response and adverse-effect reasoning | |
salicylate | analyte measured in evaluation of salicylate exposure | Two salicylate concentrations are listed with their individual collection times. | Objective | Drug levels - named analytes and exposure reports |
sensitization | development of immune reactivity to an exposure | Prior testing documents contact sensitization to the adhesive. | Assessment | Risk, goals, medication assessment and function |
steady-state concentration | concentration at a specified point once repeated-dose exposure has stabilized | The reported steady-state concentration refers to the predose point in the dosing interval. | Assessment | Drug levels - exposure and pharmacokinetics |
suspected common source | one exposure may account for multiple cases | The suspected common source was considered because attendees reported illness after the same meal. | Assessment | Infection course, epidemiology and source attribution |
symptom correlation | linking a reported symptom to a measurement or exposure over time | Review the diary for symptom correlation with the concentration changes. | Plan | Monitoring actions, escalation and result communication |
target attainment | achievement of the defined treatment exposure goal | Evaluate target attainment only after checking the metric, timing and comparator. | Plan | Drug levels - verification and documentation |